Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cisplatin"" wg kryterium: Temat


Starter badań:

Tytuł :
Protective effects of low-temperature plasma on cisplatin-induced nephrotoxicity.
Autorzy :
Guo P; Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, 100044, China.
Zhang N; Department of Comparative Medicine, Laboratory Animal Center, Dalian Medical University, Dalian 116044, Liaoning, China.
Li J; Yantai Healing Technology Co. Ltd., Yantai 264006, Shandong, China.
Liu Y; Department of Comparative Medicine, Laboratory Animal Center, Dalian Medical University, Dalian 116044, Liaoning, China.
Li Y; Yantai Healing Technology Co. Ltd., Yantai 264006, Shandong, China.
Wang X; Yantai Healing Technology Co. Ltd., Yantai 264006, Shandong, China.
Wang J; Department of Comparative Medicine, Laboratory Animal Center, Dalian Medical University, Dalian 116044, Liaoning, China. Electronic address: .
Wang Y; Yantai Healing Technology Co. Ltd., Yantai 264006, Shandong, China. Electronic address: .
Wang A; Department of Comparative Medicine, Laboratory Animal Center, Dalian Medical University, Dalian 116044, Liaoning, China. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2022 Jan 15; Vol. 289, pp. 120230. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji :
Journal Article
MeSH Terms :
Cisplatin*/adverse effects
Cisplatin*/pharmacology
Kidney*/metabolism
Kidney*/pathology
Kidney Diseases*/chemically induced
Kidney Diseases*/metabolism
Kidney Diseases*/pathology
Kidney Diseases*/prevention & control
Gene Expression Regulation/*drug effects
Plasma Gases/*pharmacology
Animals ; Cell Line, Tumor ; Male ; Mice ; Mice, Inbred ICR ; Neoplasms, Experimental/drug therapy ; Neoplasms, Experimental/metabolism ; Neoplasms, Experimental/pathology ; Rats ; Rats, Wistar
Czasopismo naukowe
Tytuł :
Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains.
Autorzy :
Lv Y; Gastroenterology Department, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310051, Zhejiang, China.
Zhang CD; Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 31005, Zhejiang, China.
Wang YL; Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 31005, Zhejiang, China.
Zhou DM; Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 31005, Zhejiang, China.
Zhu MY; Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 31005, Zhejiang, China.
Hao XQ; Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 31005, Zhejiang, China.
Wang JH; Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 31005, Zhejiang, China.
Gu WZ; Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 31005, Zhejiang, China.
Shen HQ; Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 31005, Zhejiang, China.
Lou JG; Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 31005, Zhejiang, China.
Wu BQ; University of Chinese Academy of Sciences, Shenzhen Hospital, Shenzhen, 518000, China.
Chen PC; University of Chinese Academy of Sciences, Shenzhen Hospital, Shenzhen, 518000, China.
Zhao ZY; Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 31005, Zhejiang, China. .
Pokaż więcej
Źródło :
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2021 Nov; Vol. 24 (6), pp. 1293-1306. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Cisplatin/*therapeutic use
Stomach Neoplasms/*drug therapy
Animals ; Antineoplastic Agents/administration & dosage ; Cell Line, Tumor/drug effects ; Cell Proliferation/drug effects ; Cisplatin/administration & dosage ; Cisplatin/pharmacology ; Disease Models, Animal ; Drug Resistance, Neoplasm/drug effects ; Drug Synergism ; Humans ; Male ; Membrane Microdomains/metabolism ; Mice ; Mice, Nude ; Sphingomyelin Phosphodiesterase/metabolism ; Stomach Neoplasms/metabolism ; Stomach Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Hymenialdisine is Cytotoxic Against Cisplatin-Sensitive but Not Against Cisplatin-Resistant Cell Lines.
Autorzy :
Abdullah N; Departments of Biochemistry.
Al Balushi N; Departments of Biochemistry.
Hasan SI; Department of Chemistry, College of Science, Sultan Qaboos University.
Al Bahlani S; Allied Health Sciences.
Dobretsov S; Center of Excellence in Marine Biotechnology, Sultan Qaboos University, Muscat, Oman.
Tamimi Y; Departments of Biochemistry.
Burney IA; Medicine, College of Medicine and Health Sciences.
Pokaż więcej
Źródło :
Sultan Qaboos University medical journal [Sultan Qaboos Univ Med J] 2021 Nov; Vol. 21 (4), pp. 632-634. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
MeSH Terms :
Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Ovarian Neoplasms*/drug therapy
Azepines ; Cell Line, Tumor ; Drug Resistance, Neoplasm ; Humans ; Pyrroles
Czasopismo naukowe
Tytuł :
Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
Autorzy :
Wang Z; Department of Obstetrics and Gynecology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China. Electronic address: .
Li F; Department of Obstetrics and Gynecology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
He S; Department of Health Statistics and Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Zhao L; Department of Obstetrics and Gynecology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Wang F; Department of Obstetrics and Gynecology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Pokaż więcej
Źródło :
Gene [Gene] 2022 Jan 30; Vol. 809, pp. 146003. Date of Electronic Publication: 2021 Oct 11.
Typ publikacji :
Journal Article
MeSH Terms :
Cisplatin/*pharmacology
Drug Resistance, Neoplasm/*drug effects
Period Circadian Proteins/*genetics
Uterine Cervical Neoplasms/*drug therapy
Animals ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Apoptosis/genetics ; Cell Line, Tumor ; Cisplatin/administration & dosage ; Drug Chronotherapy ; Drug Resistance, Neoplasm/genetics ; Epithelial-Mesenchymal Transition/genetics ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Mice, Nude ; Period Circadian Proteins/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Transcription Factor RelA/genetics ; Transcription Factor RelA/metabolism ; Uterine Cervical Neoplasms/genetics ; Uterine Cervical Neoplasms/metabolism ; Uterine Cervical Neoplasms/pathology ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
Autorzy :
Li J; Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China.
Liu H; Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China.
Li Y; Department of Radiology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China.
Li J; Clinical Research Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China.
Shen L; Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China.
Long W; Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China.
Yang C; Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China.
Xu H; Department of Radiotherapy, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China.
Xi W; Department of Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China.
Cai R; Department of Radiotherapy, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China. .
Feng W; Department of Gynecology and Obstetrics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People's Republic of China. .
Pokaż więcej
Źródło :
Trials [Trials] 2022 Jan 10; Vol. 23 (1), pp. 29. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji :
Clinical Trial Protocol; Journal Article
MeSH Terms :
Cisplatin*
Uterine Cervical Neoplasms*/pathology
Antineoplastic Combined Chemotherapy Protocols ; Chemoradiotherapy ; Clinical Trials, Phase III as Topic ; Female ; Humans ; Multicenter Studies as Topic ; Neoadjuvant Therapy ; Neoplasm Staging ; Paclitaxel ; Prospective Studies ; Quality of Life ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013.
Autorzy :
Hironaka S; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Yufu, Japan.
Sadachi R; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Machida N; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
Iwasa S; Division of Gastrointestinal Medical Oncology, National Cancer Centre Hospital, Tokyo, Japan.
Yamada Y; Comprehensive Cancer Center, National Center for Global Health and Medicine, Tokyo, Japan.; Department of Medical Oncology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Sasako M; Department of Surgery, Yodogawa Christian Hospital, Osaka, Japan.
Yoshikawa T; Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan.
Boku N; Division of Gastrointestinal Medical Oncology, National Cancer Centre Hospital, Tokyo, Japan.
Terashima M; Division of Gastric Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Pokaż więcej
Źródło :
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2022 Jan 03; Vol. 52 (1), pp. 14-23.
Typ publikacji :
Journal Article
MeSH Terms :
Cisplatin*/adverse effects
Stomach Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Docetaxel/adverse effects ; Humans ; Kidney/physiology ; Taxoids/adverse effects
Czasopismo naukowe
Tytuł :
Impact of cisplatin administration on cerebellar cortical structure and locomotor activity of infantile and juvenile albino rats: the role of oxidative stress.
Autorzy :
Mokhtar HEL; Human Anatomy and Embryology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Hulail MAE; Human Anatomy and Embryology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Mahmoud SM; Human Anatomy and Embryology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. .
Yousef DM; Human Anatomy and Embryology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Pokaż więcej
Źródło :
Anatomical science international [Anat Sci Int] 2022 Jan; Vol. 97 (1), pp. 30-47. Date of Electronic Publication: 2021 Aug 13.
Typ publikacji :
Journal Article
MeSH Terms :
Cisplatin*/toxicity
Oxidative Stress*
Animals ; Cerebellar Cortex ; Locomotion ; Rats ; Rats, Wistar
Czasopismo naukowe
Tytuł :
Cisplatin induces TRPA1-mediated mechanical allodynia in the oral mucosa.
Autorzy :
Nakatomi C; Division of Physiology, Kyushu Dental University, Fukuoka, Japan.
Hitomi S; Department of Physiology, Nihon University School of Dentistry, Tokyo, Japan.
Yamaguchi K; Division of Physiology, Kyushu Dental University, Fukuoka, Japan.
Hsu CC; Division of Physiology, Kyushu Dental University, Fukuoka, Japan.
Seta Y; Division of Anatomy, Kyushu Dental University, Fukuoka, Japan.
Harano N; Division of Dental Anesthesiology, Kyushu Dental University, Fukuoka, Japan.
Iwata K; Department of Physiology, Nihon University School of Dentistry, Tokyo, Japan.
Ono K; Division of Physiology, Kyushu Dental University, Fukuoka, Japan. Electronic address: .
Pokaż więcej
Źródło :
Archives of oral biology [Arch Oral Biol] 2022 Jan; Vol. 133, pp. 105317. Date of Electronic Publication: 2021 Nov 16.
Typ publikacji :
Journal Article
MeSH Terms :
Cisplatin*/toxicity
Peripheral Nervous System Diseases*
Animals ; Humans ; Hyperalgesia/chemically induced ; Mouth Mucosa ; Rats ; TRPA1 Cation Channel
Czasopismo naukowe
Tytuł :
Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action.
Autorzy :
Tanini D; University of Florence, Department of Chemistry 'Ugo Schiff', Via Della Lastruccia 3-13, I-50019, Sesto Fiorentino, Italy.
Carradori S; Department of Pharmacy, 'G. D'Annunzio' University of Chieti-Pescara, Chieti, Italy.
Capperucci A; University of Florence, Department of Chemistry 'Ugo Schiff', Via Della Lastruccia 3-13, I-50019, Sesto Fiorentino, Italy.
Lupori L; University of Florence, Department of Chemistry 'Ugo Schiff', Via Della Lastruccia 3-13, I-50019, Sesto Fiorentino, Italy.
Zara S; Department of Pharmacy, 'G. D'Annunzio' University of Chieti-Pescara, Chieti, Italy.
Ferraroni M; University of Florence, Department of Chemistry 'Ugo Schiff', Via Della Lastruccia 3-13, I-50019, Sesto Fiorentino, Italy.
Ghelardini C; Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Firenze, Firenze, Italy.
Mannelli L; Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Firenze, Firenze, Italy.
Micheli L; Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Firenze, Firenze, Italy.
Lucarini E; Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Firenze, Firenze, Italy.
Carta F; NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Florence, Italy.
Angeli A; NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Florence, Italy; Centre of Advanced Research in Bionanoconjugates and Biopolymers Department, 'Petru Poni' Institute of Macromolecular Chemistry, 707410, Iasi, Romania. Electronic address: .
Supuran CT; NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Florence, Italy.
Pokaż więcej
Źródło :
European journal of medicinal chemistry [Eur J Med Chem] 2021 Dec 05; Vol. 225, pp. 113793. Date of Electronic Publication: 2021 Aug 23.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*pharmacology
Carbonic Anhydrase Inhibitors/*pharmacology
Carbonic Anhydrases/*metabolism
Chalcogens/*pharmacology
Cisplatin/*pharmacology
Neuralgia/*drug therapy
Administration, Oral ; Animals ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/chemistry ; Carbonic Anhydrase Inhibitors/administration & dosage ; Carbonic Anhydrase Inhibitors/chemistry ; Cell Proliferation/drug effects ; Chalcogens/chemical synthesis ; Chalcogens/chemistry ; Cisplatin/administration & dosage ; Cisplatin/chemistry ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Humans ; Isoenzymes/antagonists & inhibitors ; Isoenzymes/metabolism ; MCF-7 Cells ; Male ; Mice ; Molecular Structure ; Neuralgia/chemically induced ; Oxaliplatin ; Oxidative Stress/drug effects ; Pain Measurement ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin.
Autorzy :
Taheri M; Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shoorei H; Department of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Tondro Anamag F; Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Ghafouri-Fard S; Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: .
Dinger ME; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia. Electronic address: .
Pokaż więcej
Źródło :
Experimental and molecular pathology [Exp Mol Pathol] 2021 Dec; Vol. 123, pp. 104602. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cisplatin/*therapeutic use
MicroRNAs/*genetics
Neoplasms/*drug therapy
RNA, Long Noncoding/*genetics
Apoptosis/drug effects ; Cell Proliferation/drug effects ; Cisplatin/adverse effects ; Drug Resistance, Neoplasm/genetics ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Neoplasms/genetics ; Progression-Free Survival
Czasopismo naukowe
Tytuł :
Cisplatin induces lung cell cilia disruption and lung damage via oxidative stress.
Autorzy :
Han YK; Department of Anatomy and BK21 Plus, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Junggu, Daegu, 41944, Republic of Korea.
Kim JS; Department of Anatomy and BK21 Plus, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Junggu, Daegu, 41944, Republic of Korea.
Jang G; Department of Anatomy and BK21 Plus, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Junggu, Daegu, 41944, Republic of Korea.
Park KM; Department of Anatomy and BK21 Plus, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Junggu, Daegu, 41944, Republic of Korea; Cardiovascular Research Institute, Kyungpook National University, 680 Gukchaebosang-ro, Junggu, Daegu, 41944, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
Free radical biology & medicine [Free Radic Biol Med] 2021 Dec; Vol. 177, pp. 270-277. Date of Electronic Publication: 2021 Oct 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cilia*/metabolism
Cisplatin*/toxicity
Animals ; Antioxidants/metabolism ; Lung/metabolism ; Mice ; Oxidative Stress
Czasopismo naukowe
Tytuł :
Sequence of CX-4945 and Cisplatin Administration Determines the Effectiveness of Drug Combination and Cellular Response in Cholangiocarcinoma Cells In Vitro .
Autorzy :
Lertsuwan J; Laboratory of Immunology, Chulabhorn Research Institute, Bangkok, Thailand.
Sawasdichai A; Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok, Thailand.
Tasnawijitwong N; Laboratory of Pharmacology, Chulabhorn Research Institute, Bangkok, Thailand.
Gaston K; Division of Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, U.K.
Jayaraman PS; Division of Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, U.K.
Satayavivad J; Laboratory of Pharmacology, Chulabhorn Research Institute, Bangkok, Thailand; .
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Dec; Vol. 41 (12), pp. 6155-6167.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Cholangiocarcinoma/*drug therapy
Cisplatin/*therapeutic use
Naphthyridines/*therapeutic use
Phenazines/*therapeutic use
Antineoplastic Agents/pharmacology ; Cell Proliferation ; Cisplatin/pharmacology ; Drug Combinations ; Drug Synergism ; Humans ; Naphthyridines/pharmacology ; Phenazines/pharmacology
Czasopismo naukowe
Tytuł :
Diclofenac potentiates the antitumor effect of cisplatin in a xenograft mouse model transplanted with cisplatin-resistant cells without enhancing cisplatin-induced nephrotoxicity.
Autorzy :
Okamoto K; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo, 060-0812, Japan.
Ueda H; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo, 060-0812, Japan.
Saito Y; Department of Pharmacy, Hokkaido University Hospital, Kita-14-jo, Nishi-5-chome, Kita-ku, Sapporo, 060-8648, Japan.
Narumi K; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo, 060-0812, Japan.
Furugen A; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo, 060-0812, Japan.
Kobayashi M; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo, 060-0812, Japan. Electronic address: .
Pokaż więcej
Źródło :
Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2021 Dec; Vol. 41, pp. 100417. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents*/pharmacology
Cisplatin*/pharmacology
A549 Cells ; Animals ; Diclofenac/pharmacology ; Heterografts ; Humans ; Mice
Czasopismo naukowe
Tytuł :
The effects of ethyl pyruvate against experimentally induced cisplatin ototoxicity in rats.
Autorzy :
Ayral M; Department of Otorhinolaryngology, Dicle University Medical Faculty, Diyarbakir, Turkey.
Toprak SF; Department of Otorhinolaryngology, Dicle University Medical Faculty, Diyarbakir, Turkey.
Pokaż więcej
Źródło :
Somatosensory & motor research [Somatosens Mot Res] 2021 Dec; Vol. 38 (4), pp. 347-352. Date of Electronic Publication: 2021 Oct 12.
Typ publikacji :
Journal Article
MeSH Terms :
Cisplatin*/toxicity
Ototoxicity*
Animals ; Pyruvates ; Rats ; Rats, Wistar
Czasopismo naukowe
Tytuł :
Pathological response and clinical outcomes in operable triple-negative breast cancer with cisplatin added to standard neoadjuvant chemotherapy.
Autorzy :
Georgy JT
Singh A
John AO
Joel A
Andrews AG
Thumaty DB
Rebekah G
Sigamani E
Chandramohan J
Manipadam MT
Cherian AJ
Abraham DT
Paul MJ
Balakrishnan R
Backianathan S
Chacko RT
Pokaż więcej
Transliterated Title :
Patologická odpoveď a klinické výsledky při léčbě operabilního triple negativního karcinomu prsu cisplatinou přidanou k standardní neoadjuvantní chemoterapii.
Źródło :
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti [Klin Onkol] 2021 Winter; Vol. 34 (1), pp. 49-55.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*administration & dosage
Cisplatin/*administration & dosage
Cyclophosphamide/*administration & dosage
Doxorubicin/*administration & dosage
Epirubicin/*administration & dosage
Paclitaxel/*administration & dosage
Triple Negative Breast Neoplasms/*drug therapy
Adult ; Anemia/chemically induced ; Antineoplastic Agents/adverse effects ; Cisplatin/adverse effects ; Cyclophosphamide/adverse effects ; Doxorubicin/adverse effects ; Drug Therapy, Combination ; Epirubicin/adverse effects ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Staging ; Paclitaxel/adverse effects ; Retrospective Studies ; Treatment Outcome ; Triple Negative Breast Neoplasms/pathology ; Triple Negative Breast Neoplasms/surgery ; Young Adult
Czasopismo naukowe
Tytuł :
Enhancing cisplatin anticancer effectivity and migrastatic potential by modulation of molecular weight of oxidized dextran carrier.
Autorzy :
Münster L; Centre of Polymer Systems, Tomas Bata University in Zlín, tř. Tomáše Bati 5678, CZ-760 01 Zlín, Czech Republic.
Fojtů M; Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00, Brno, Czech Republic; Center for Advanced Functional Nanorobots, Department of Inorganic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology in Prague, Technická 5, Prague CZ-166 28, Czech Republic; Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00 Brno, Czech Republic.
Muchová M; Centre of Polymer Systems, Tomas Bata University in Zlín, tř. Tomáše Bati 5678, CZ-760 01 Zlín, Czech Republic.
Latečka F; Centre of Polymer Systems, Tomas Bata University in Zlín, tř. Tomáše Bati 5678, CZ-760 01 Zlín, Czech Republic.
Káčerová S; Centre of Polymer Systems, Tomas Bata University in Zlín, tř. Tomáše Bati 5678, CZ-760 01 Zlín, Czech Republic.
Capáková Z; Centre of Polymer Systems, Tomas Bata University in Zlín, tř. Tomáše Bati 5678, CZ-760 01 Zlín, Czech Republic.
Juriňáková T; Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00, Brno, Czech Republic; Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00 Brno, Czech Republic.
Kuřitka I; Centre of Polymer Systems, Tomas Bata University in Zlín, tř. Tomáše Bati 5678, CZ-760 01 Zlín, Czech Republic.
Masařík M; Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00, Brno, Czech Republic; Center for Advanced Functional Nanorobots, Department of Inorganic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology in Prague, Technická 5, Prague CZ-166 28, Czech Republic; Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00 Brno, Czech Republic; BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 252 50, Vestec, Czech Republic. Electronic address: .
Vícha J; Centre of Polymer Systems, Tomas Bata University in Zlín, tř. Tomáše Bati 5678, CZ-760 01 Zlín, Czech Republic. Electronic address: .
Pokaż więcej
Źródło :
Carbohydrate polymers [Carbohydr Polym] 2021 Nov 15; Vol. 272, pp. 118461. Date of Electronic Publication: 2021 Jul 21.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*pharmacology
Cisplatin/*pharmacology
Dextrans/*chemistry
Drug Carriers/*chemistry
Neoplasms/*drug therapy
A549 Cells ; Adenocarcinoma/drug therapy ; Adenocarcinoma/metabolism ; Antineoplastic Agents/chemistry ; Cell Movement/drug effects ; Cisplatin/chemistry ; Drug Delivery Systems/methods ; Female ; Humans ; Male ; Molecular Weight ; Nanogels/chemistry ; Neoplasms/metabolism ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/metabolism ; Oxidation-Reduction ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/metabolism
Czasopismo naukowe
Tytuł :
Methylseleninic acid overcomes programmed death-ligand 1-mediated resistance of prostate cancer and lung cancer.
Autorzy :
Hu W; College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
Ma Y; College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
Zhao C; College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
Yin S; College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
Hu H; College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2021 Nov; Vol. 60 (11), pp. 746-757. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
B7-H1 Antigen/*metabolism
Cisplatin/*administration & dosage
Drug Resistance, Neoplasm/*drug effects
Lung Neoplasms/*drug therapy
Organoselenium Compounds/*administration & dosage
Prostatic Neoplasms/*drug therapy
A549 Cells ; Animals ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Cisplatin/pharmacology ; Drug Synergism ; Humans ; Interferon-gamma/metabolism ; Lung Neoplasms/metabolism ; Male ; Mice ; Organoselenium Compounds/pharmacology ; Phosphorylation ; Prostatic Neoplasms/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Evaluation of protective effects of gallic acid on cisplatin-induced testicular and epididymal damage.
Autorzy :
Altındağ F; Department of Histology and Embryology, Van Yüzüncü Yıl University, Van, Turkey.
Meydan İ; Department of Biochemistry, Van Vocational Higher School of Healthcare Studies, Van Yüzüncü Yıl University, Van, Turkey.
Pokaż więcej
Źródło :
Andrologia [Andrologia] 2021 Nov; Vol. 53 (10), pp. e14189. Date of Electronic Publication: 2021 Jul 15.
Typ publikacji :
Journal Article
MeSH Terms :
Cisplatin*/toxicity
Epididymis*
Animals ; Antioxidants/metabolism ; Antioxidants/pharmacology ; Gallic Acid/pharmacology ; Male ; Oxidative Stress ; Rats ; Spermatozoa/metabolism ; Testis/metabolism
Czasopismo naukowe
Tytuł :
Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial.
Autorzy :
Aramaki O; Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
Takayama T; Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan. Electronic address: .
Moriguchi M; Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
Sakamoto H; Center for Digestive and Liver Diseases, Miyazaki Medical Center Hospital, Miyazaki, Japan.
Yodono H; Department of Radiology, Narumi Hospital, Hirosaki, Japan.
Kokudo N; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, University of Tokyo, Tokyo, Japan.
Yamanaka N; Department of Surgery, Meiwa Hospital, Hyogo, Japan.
Kawasaki S; Department of Hepato-Biliary-Pancreatic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Sasaki Y; Department of Surgery, Yao Municipal Hospital, Osaka, Japan.
Kubota K; Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.
Otsuji E; Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Tanaka S; Department of Hepato-Biliary-Pancreatic Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Matsuyama Y; Department of Biostatistics, University of Tokyo, Tokyo, Japan.
Fujii M; Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan.
Pokaż więcej
Corporate Authors :
ACE 500 study group
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Nov; Vol. 157, pp. 373-382. Date of Electronic Publication: 2021 Sep 23.
Typ publikacji :
Clinical Trial, Phase II; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular/*therapy
Chemoembolization, Therapeutic/*methods
Cisplatin/*administration & dosage
Epirubicin/*administration & dosage
Liver Neoplasms/*therapy
Aged ; Carcinoma, Hepatocellular/blood supply ; Carcinoma, Hepatocellular/mortality ; Chemoembolization, Therapeutic/adverse effects ; Cisplatin/adverse effects ; Epirubicin/adverse effects ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Liver/blood supply ; Liver/pathology ; Liver Neoplasms/blood supply ; Male ; Middle Aged ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.
Autorzy :
Magnes T; IIIrd Medical Department, Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Salzburg Cancer Research Institute, Müllner Hauptstraße 48, 5020, Salzburg, Austria.
Wagner SM; IIIrd Medical Department, Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Salzburg Cancer Research Institute, Müllner Hauptstraße 48, 5020, Salzburg, Austria.
Melchardt T; IIIrd Medical Department, Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Salzburg Cancer Research Institute, Müllner Hauptstraße 48, 5020, Salzburg, Austria.
Weiss L; IIIrd Medical Department, Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Salzburg Cancer Research Institute, Müllner Hauptstraße 48, 5020, Salzburg, Austria.
Rinnerthaler G; IIIrd Medical Department, Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Salzburg Cancer Research Institute, Müllner Hauptstraße 48, 5020, Salzburg, Austria.
Huemer F; IIIrd Medical Department, Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Salzburg Cancer Research Institute, Müllner Hauptstraße 48, 5020, Salzburg, Austria.
Kopp M; Abteilung für Innere Medizin IV, Hämatologie, internistische Onkologie und Palliativmedizin, Nephrologie und Dialyse, Klinikum Wels-Grieskirchen GmbH, Grieskirchner Straße 42, 4600, Wels, Austria.
Gampenrieder SP; IIIrd Medical Department, Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Salzburg Cancer Research Institute, Müllner Hauptstraße 48, 5020, Salzburg, Austria.
Mayrbäurl B; Abteilung für Innere Medizin IV, Hämatologie, internistische Onkologie und Palliativmedizin, Nephrologie und Dialyse, Klinikum Wels-Grieskirchen GmbH, Grieskirchner Straße 42, 4600, Wels, Austria.
Füreder T; Universitätsklinik für Innere Medizin I: Klinische Abteilung für Onkologie, AKH Meduni Wien, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Lenger D; Med. Campus III-Hämatologie und Internistische Onkologie, Kepler Universitätsklinikum GmbH Linz, Krankenhausstraße 9, 4021, Linz, Austria.
Andel J; Abteilung für Innere Medizin 2, Pyhrn-Eisenwurzen Klinikum Steyr, Sierninger Straße 170, 4400, Steyr, Austria.
Egle A; IIIrd Medical Department, Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Salzburg Cancer Research Institute, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Cancer Cluster Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria.
Greil R; IIIrd Medical Department, Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria. .; Salzburg Cancer Research Institute, Müllner Hauptstraße 48, 5020, Salzburg, Austria. .; Cancer Cluster Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria. .
Pokaż więcej
Źródło :
Wiener klinische Wochenschrift [Wien Klin Wochenschr] 2021 Nov; Vol. 133 (21-22), pp. 1131-1136. Date of Electronic Publication: 2021 Sep 15.
Typ publikacji :
Journal Article
MeSH Terms :
Cisplatin*
Head and Neck Neoplasms*
Austria ; Cetuximab ; Chemoradiotherapy ; Humans ; Radioimmunotherapy ; Registries
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies